Immune cells breakthrough could help to delay onset of type 1 diabetes

A trial involving a subset of immune cells could mean researchers are one step closer to preventing type 1 diabetes.

The research, carried out by the Baylor College of Medicine and the University of Michigan Medical School, was based around a group of immune B cells, known as CD19+IgM+ B cells and the role they play in the immune system.

Through their work, they were able to delay the onset of the condition in mice